Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00752258 · ClinicalTrials.gov registry record · Phase 3
A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows
A Phase 3 study, sponsored by Mentor Worldwide.
- Completed
- Registry status
- Phase 3
- Development phase
- 576
- Enrollment target
NCT00752258: Completed Phase 3 study, sponsored by Mentor Worldwide.
NCT00752258 is a Phase 3 study that has completed, run by Mentor Worldwide. The registered enrollment target is 576 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00752258, a Phase 3 study, has completed, sponsored by Mentor Worldwide.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 576 participants
- Enrollment target
Study Summary
The overall purpose of this study is to evaluate the long-term safety of repeat treatment with an intramuscular dose of Mentor Purified Toxin for the reduction of frown lines.
Interventions
- DRUG Mentor Purified Toxin Botulinum Toxin Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 576 participants |
| Start Date | 2008-02 |
| Est. Completion | 2011-05 |
| Phase | Phase 3 |
What the finished NCT00752258 record still lists
NCT00752258 is an interventional study that assigns participants to a tested intervention. The registered 576 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (25% lower).
The record links to 0 conditions, and to 1 intervention - of which Mentor Purified Toxin Botulinum Toxin Type A is the first listed.
NCT00752258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00752258 about?
NCT00752258 is a clinical study titled "A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows". The overall purpose of this study is to evaluate the long-term safety of repeat treatment with an intramuscular dose of Mentor Purified Toxin for the reduction of frown lines.
What is the current status of trial NCT00752258?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 576 participants. The study started on 2008-02. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00752258?
The interventions under investigation include: Mentor Purified Toxin Botulinum Toxin Type A (DRUG).
Who is sponsoring clinical trial NCT00752258?
This trial is sponsored by Mentor Worldwide, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00752258's enrollment target sits among peer trials
576 661st of 2000 higher than 1,340 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04931810 · 576 participants · NA
Urban and Reservation Implementation of All Nations Breath of Life
- NCT05179369 · 576 participants · NA
Well-Mama Community Doula Navigator Study
- NCT06398509 · 576 participants · NA
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia